Brandes reports 1.03M LENSAR shares (8.48%)
Brandes Investment Partners amended a Schedule 13G to report beneficial ownership of 1,026,018 common shares of LENSAR, Inc., representing 8.48% of the class as of 09/30/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Brandes Investment Partners amended a Schedule 13G to report beneficial ownership of 1,026,018 common shares of LENSAR, Inc., representing 8.48% of the class as of 09/30/2025. The amendment lists shared voting power of 937,207 shares and shared dispositive power of 1,026,018 shares. The filing is signed by Executive Director Glenn Carlson on 05/07/2026.
Insights
Brandes holds an 8.48% stake in LENSAR as of 09/30/2025.
Brandes Investment Partners reports 1,026,018 shares beneficially owned with shared voting power of 937,207 shares. The Schedule 13G/A amendment restates its position rather than indicating a transaction within this excerpt.
Ownership disclosures like this clarify institutional stakes and potential governance influence; subsequent filings may show changes in voting or disposition but timing is not specified in the excerpt.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What form was filed to disclose Brandes' LENSAR stake?
When was the Schedule 13G/A signed and by whom?
AI-generated analysis. How Rhea-AI works. Not financial advice.